name,category,termsArfGAP with dual PH domains 1,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with dual PH domains 1,PIR_SUPERFAMILY[630029700$PIRSF038114:Centaurin-alpha 1/2]
ArfGAP with dual PH domains 1,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH]
ArfGAP with dual PH domains 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000191$blood, 790000199$brain, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
ArfGAP with dual PH domains 1,UP_SEQ_FEATURE[850006009$chain:Arf-GAP with dual PH domain-containing protein 1, 850103059$domain:Arf-GAP, 850104980$domain:PH 1, 850104981$domain:PH 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118762$zinc finger region:C4-type]
CCR4-NOT transcription complex, subunit 4,COG_ONTOLOGY[90000115$Transcription]
CCR4-NOT transcription complex, subunit 4,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450001628$IPR001841:Zinc finger, RING-type, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
CCR4-NOT transcription complex, subunit 4,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
CCR4-NOT transcription complex, subunit 4,SMART[760000158$SM00184:RING, 760000328$SM00360:RRM]
CCR4-NOT transcription complex, subunit 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
CCR4-NOT transcription complex, subunit 4,UP_SEQ_FEATURE[850010114$chain:CCR4-NOT transcription complex subunit 4, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn, 850118751$zinc finger region:C3H1-type, 850118920$zinc finger region:RING-type; degenerate]
CD200 receptor 1-like,INTERPRO[450006486$IPR007110:Immunoglobulin-like]
CD200 receptor 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
CD200 receptor 1-like,UP_SEQ_FEATURE[850010498$chain:Cell surface glycoprotein CD200 receptor 2, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ELKS/RAB6-interacting/CAST family member 2,INTERPRO[450017561$IPR019323:CAZ complex, RIM-binding protein]
ELKS/RAB6-interacting/CAST family member 2,OMIM_DISEASE[520002056$Genome-wide association with bone mass and geometry in the Framingham Heart Study]
ELKS/RAB6-interacting/CAST family member 2,SP_PIR_KEYWORDS[790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism, 790001475$synapse, 790001477$Synaptosome]
ELKS/RAB6-interacting/CAST family member 2,UP_SEQ_FEATURE[850017773$chain:ERC protein 2, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117295$sequence variant]
KIAA1919,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
KIAA1919,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001457$sugar transport, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
KIAA1919,UP_SEQ_FEATURE[850061218$chain:Sodium-dependent glucose transporter 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MPN domain containing,INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1]
MPN domain containing,SMART[760000204$SM00232:JAB_MPN]
MPN domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001162$phosphoprotein, 790001252$Protease]
MPN domain containing,UP_SEQ_FEATURE[850032533$chain:MPN domain-containing protein, 850102517$compositionally biased region:Gly-rich, 850102572$compositionally biased region:Poly-Glu, 850104794$domain:MPN, 850106258$modified residue, 850117294$sequence conflict, 850117527$short sequence motif:JAMM motif, 850118574$splice variant]
PDX1 C-terminal inhibiting factor 1,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP]
PDX1 C-terminal inhibiting factor 1,SMART[760000401$SM00456:WW]
PDX1 C-terminal inhibiting factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein]
PDX1 C-terminal inhibiting factor 1,UP_SEQ_FEATURE[850038949$chain:Phosphorylated CTD-interacting factor 1, 850102581$compositionally biased region:Poly-Ser, 850105731$domain:WW, 850105852$helix, 850106258$modified residue, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn]
Rho guanine nucleotide exchange factor (GEF) 5-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
Rho guanine nucleotide exchange factor (GEF) 5-like,UP_SEQ_FEATURE[850057576$chain:Rho guanine nucleotide exchange factor 5- like protein, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117294$sequence conflict]
Scm-like with four mbt domains 1,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450003607$IPR004092:Mbt repeat, 450012380$IPR013761:Sterile alpha motif-type]
Scm-like with four mbt domains 1,SMART[760000399$SM00454:SAM, 760000500$SM00561:MBT]
Scm-like with four mbt domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
Scm-like with four mbt domains 1,UP_SEQ_FEATURE[850058998$chain:Scm-like with four MBT domains protein 1, 850105249$domain:SAM, 850106258$modified residue, 850110936$region of interest:Antigenic epitope, 850116372$repeat:MBT 1, 850116373$repeat:MBT 2, 850116374$repeat:MBT 3, 850116375$repeat:MBT 4, 850117294$sequence conflict, 850118574$splice variant]
T-box 10,INTERPRO[450001505$IPR001699:Transcription factor, T-box, 450016474$IPR018186:Transcription factor, T-box, conserved site]
T-box 10,SMART[760000371$SM00425:TBOX]
T-box 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
T-box 10,UP_SEQ_FEATURE[850063328$chain:T-box transcription factor TBX10, 850102955$DNA-binding region:T-box, 850117294$sequence conflict, 850117295$sequence variant]
WD repeat domain 74,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup]
WD repeat domain 74,SMART[760000289$SM00320:WD40]
WD repeat domain 74,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 74,UP_SEQ_FEATURE[850100776$chain:WD repeat-containing protein 74, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850118574$splice variant]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B,INTERPRO[450007252$IPR007904:APOBEC-like, C-terminal, 450011795$IPR013158:APOBEC-like, N-terminal, 450014525$IPR016192:APOBEC/CMP deaminase, zinc-binding]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism, 790001339$rna-binding, 790001648$zinc]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850041737$chain:Probable DNA dC->dU-editing enzyme APOBEC-3B, 850106218$metal ion-binding site:Zinc, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 16 open reading frame 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 16 open reading frame 62,UP_SEQ_FEATURE[850097628$chain:UPF0505 protein C16orf62, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 55,UP_SEQ_FEATURE[850073524$chain:Uncharacterized protein C19orf55, 850102597$compositionally biased region:Ser-rich, 850117295$sequence variant, 850118574$splice variant]
chromosome 7 open reading frame 41,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 7 open reading frame 41,UP_SEQ_FEATURE[850097078$chain:UPF0452 protein C7orf41, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850118574$splice variant]
complement component 9,BIOCARTA[30000016$h_alternativePathway:Alternative Complement Pathway, 30000066$h_classicPathway:Classical Complement Pathway, 30000067$h_compPathway:Complement Pathway, 30000171$h_lectinPathway:Lectin Induced Complement Pathway]
complement component 9,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450001647$IPR001862:Membrane attack complex component/perforin/complement C9, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450011699$IPR013032:EGF-like region, conserved site]
complement component 9,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038895$hsa05020:Prion diseases, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 9,OMIM_DISEASE[520000730$C9 deficiency, 520000731$C9 deficiency with dermatomyositis]
complement component 9,PIR_SUPERFAMILY[630002597$PIRSF002481:complement C9]
complement component 9,SMART[760000166$SM00192:LDLa, 760000182$SM00209:TSP1, 760000402$SM00457:MACPF]
complement component 9,SP_PIR_KEYWORDS[790000264$cell membrane, 790000352$complement alternate pathway, 790000355$complement pathway, 790000356$complete proteome, 790000406$cytolysis, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000763$immune response, 790000774$inflammation, 790000777$innate immunity, 790000919$membrane, 790000921$membrane attack complex, 790000994$multimer, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
complement component 9,UP_SEQ_FEATURE[850012364$chain:complement component 9, 850012373$chain:Complement component C9, 850012374$chain:Complement component C9a, 850012375$chain:Complement component C9b, 850102883$disulfide bond, 850103596$domain:EGF-like, 850104664$domain:LDL-receptor class A, 850104738$domain:MACPF, 850105554$domain:TSP type-1, 850105756$glycosylation site:C-linked (Man), 850105759$glycosylation site:C-linked (Man); partial, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118124$site:Cleavage; by thrombin, 850118623$transmembrane region]
dullard homolog (Xenopus laevis),INTERPRO[450003783$IPR004274:NLI interacting factor, 450010773$IPR011948:Dullard-like phosphatase domain]
dullard homolog (Xenopus laevis),SMART[760000514$SM00577:CPDc]
dullard homolog (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001261$protein phosphatase, 790001555$transmembrane]
dullard homolog (Xenopus laevis),UP_SEQ_FEATURE[850060161$chain:Serine/threonine-protein phosphatase dullard, 850103756$domain:FCP1 homology, 850106259$mutagenesis site, 850117295$sequence variant, 850118623$transmembrane region]
family with sequence similarity 150, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 150, member B,UP_SEQ_FEATURE[850045884$chain:Protein FAM150B, 850117814$signal peptide, 850118574$splice variant]
farnesyltransferase, CAAX box, alpha,INTERPRO[450001850$IPR002088:Protein prenyltransferase, alpha subunit, 450008165$IPR008940:Protein prenyltransferase]
farnesyltransferase, CAAX box, alpha,PIR_SUPERFAMILY[630012876$PIRSF016105:PIRSF016105]
farnesyltransferase, CAAX box, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000679$heterodimer, 790001162$phosphoprotein, 790001237$prenyltransferase, 790001304$repeat, 790001547$transferase]
farnesyltransferase, CAAX box, alpha,UP_SEQ_FEATURE[850046112$chain:Protein farnesyltransferase/ geranylgeranyltransferase type-1 subunit alpha, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116701$repeat:PFTA 1, 850116702$repeat:PFTA 2, 850116703$repeat:PFTA 3, 850116704$repeat:PFTA 4, 850116705$repeat:PFTA 5, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
fibronectin type III and SPRY domain containing 2,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
fibronectin type III and SPRY domain containing 2,SMART[760000051$SM00060:FN3]
fibronectin type III and SPRY domain containing 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
fibronectin type III and SPRY domain containing 2,UP_SEQ_FEATURE[850019436$chain:Fibronectin type III and SPRY domain- containing protein 2, 850103078$domain:B30.2/SPRY, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850117295$sequence variant]
leucine-rich repeats and immunoglobulin-like domains 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
leucine-rich repeats and immunoglobulin-like domains 1,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
leucine-rich repeats and immunoglobulin-like domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine-rich repeats and immunoglobulin-like domains 1,UP_SEQ_FEATURE[850028452$chain:Leucine-rich repeats and immunoglobulin- like domains protein 1, 850102581$compositionally biased region:Poly-Ser, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lipin 1,INTERPRO[450007008$IPR007651:Lipin, N-terminal conserved region, 450011846$IPR013209:LNS2, Lipin/Ned1/Smp2]
lipin 1,OMIM_DISEASE[520003481$Myoglobinuria, acute recurrent, autosomal recessive]
lipin 1,SMART[760000680$SM00775:LNS2]
lipin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000543$fatty acid metabolism, 790000743$hydrolase, 790000811$isopeptide bond, 790000873$lipid metabolism, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
lipin 1,UP_SEQ_FEATURE[850038374$chain:Phosphatidate phosphatase LPIN1, 850102581$compositionally biased region:Poly-Ser, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850111125$region of interest:C-LIP, 850113515$region of interest:N-LIP, 850117295$sequence variant, 850117435$short sequence motif:DXDXT motif, 850117556$short sequence motif:LXXIL motif, 850117610$short sequence motif:Nuclear localization signal]
nicalin homolog (zebrafish),COG_ONTOLOGY[90000073$General function prediction only]
nicalin homolog (zebrafish),INTERPRO[450007965$IPR008710:Nicastrin, 450014896$IPR016574:Nicalin]
nicalin homolog (zebrafish),PIR_SUPERFAMILY[630009560$PIRSF011018:Nicalin]
nicalin homolog (zebrafish),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
nicalin homolog (zebrafish),UP_SEQ_FEATURE[850034232$chain:Nicalin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
proteasome (prosome, macropain) activator subunit 4,INTERPRO[450000307$IPR000357:HEAT]
proteasome (prosome, macropain) activator subunit 4,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) activator subunit 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001254$proteasome, 790001304$repeat, 790001426$spermatogenesis]
proteasome (prosome, macropain) activator subunit 4,UP_SEQ_FEATURE[850044823$chain:Proteasome activator complex subunit 4, 850106258$modified residue, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
protocadherin 24,INTERPRO[450001884$IPR002126:Cadherin]
protocadherin 24,SMART[760000099$SM00112:CA]
protocadherin 24,SP_PIR_KEYWORDS[790000211$calcium, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
protocadherin 24,UP_SEQ_FEATURE[850048759$chain:Protocadherin-24, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
purinergic receptor P2Y, G-protein coupled, 8,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
purinergic receptor P2Y, G-protein coupled, 8,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
purinergic receptor P2Y, G-protein coupled, 8,PIR_SUPERFAMILY[630030124$PIRSF038620:P2Y purinoceptor 8, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
purinergic receptor P2Y, G-protein coupled, 8,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
purinergic receptor P2Y, G-protein coupled, 8,UP_SEQ_FEATURE[850036632$chain:P2Y purinoceptor 8, 850102566$compositionally biased region:Poly-Arg, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
retbindin,INTERPRO[450003777$IPR004269:Folate receptor, 450016436$IPR018143:Folate receptor, conserved region]
retbindin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
retbindin,UP_SEQ_FEATURE[850057323$chain:Retbindin, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
spastin,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450006694$IPR007330:MIT, 450015499$IPR017179:Spastin]
spastin,OMIM_DISEASE[520004566$Spastic paraplegia-4]
spastin,PIR_SUPERFAMILY[630028890$PIRSF037338:spastin]
spastin,SMART[760000335$SM00382:AAA, 760000651$SM00745:MIT]
spastin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000052$alternative promoter usage, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000499$endoplasmic reticulum, 790000501$endosome, 790000675$hereditary spastic paraplegia, 790000743$hydrolase, 790000919$membrane, 790000960$microtubule, 790001015$neurodegeneration, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
spastin,UP_SEQ_FEATURE[850061583$chain:Spastin, 850104790$domain:MIT, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850114323$region of interest:Required for interaction with ATL1, 850114360$region of interest:Required for interaction with microtubules, 850114361$region of interest:Required for interaction with microtubules and microtubule severing, 850114385$region of interest:Required for interaction with RTN1, 850114389$region of interest:Required for interaction with SSNA1 and microtubules, 850114427$region of interest:Required for midbody localization, 850114436$region of interest:Required for nuclear localization, 850114748$region of interest:Sufficient for interaction with CHMP1B, 850114780$region of interest:Sufficient for interaction with microtubules, 850114801$region of interest:Sufficient for microtubule severing, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118623$transmembrane region]
stearoyl-CoA desaturase 5,INTERPRO[450001354$IPR001522:Fatty acid desaturase, type 1, C-terminal, 450005254$IPR005804:Fatty acid desaturase, type 1, 450014299$IPR015876:Fatty acid desaturase, type 1, core]
stearoyl-CoA desaturase 5,KEGG_PATHWAY[470038811$hsa01040:Biosynthesis of unsaturated fatty acids, 470038821$hsa03320:PPAR signaling pathway]
stearoyl-CoA desaturase 5,PIR_SUPERFAMILY[630000404$PIRSF000344:acyl-CoA desaturase]
stearoyl-CoA desaturase 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000542$Fatty acid biosynthesis, 790000802$iron, 790000874$lipid synthesis, 790000919$membrane, 790000937$metal-binding, 790001092$oxidoreductase, 790001555$transmembrane]
stearoyl-CoA desaturase 5,UP_SEQ_FEATURE[850062412$chain:Stearoyl-CoA desaturase 5, 850117294$sequence conflict, 850117484$short sequence motif:Histidine box-1, 850117485$short sequence motif:Histidine box-2, 850117486$short sequence motif:Histidine box-3, 850118574$splice variant, 850118623$transmembrane region]
tetratricopeptide repeat domain 21A,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
tetratricopeptide repeat domain 21A,SMART[760000020$SM00028:TPR]
tetratricopeptide repeat domain 21A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
tetratricopeptide repeat domain 21A,UP_SEQ_FEATURE[850064004$chain:Tetratricopeptide repeat protein 21A, 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117121$repeat:TPR 11, 850117122$repeat:TPR 12, 850117123$repeat:TPR 13, 850117125$repeat:TPR 14, 850117126$repeat:TPR 15, 850117127$repeat:TPR 16, 850117128$repeat:TPR 17, 850117129$repeat:TPR 18, 850117130$repeat:TPR 19, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
transforming, acidic coiled-coil containing protein 3,INTERPRO[450007062$IPR007707:Transforming acidic coiled-coil-containing]
transforming, acidic coiled-coil containing protein 3,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
transforming, acidic coiled-coil containing protein 3,UP_SEQ_FEATURE[850065744$chain:Transforming acidic coiled-coil- containing protein 3, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
ubiquitin-conjugating enzyme E2L 3,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2L 3,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038892$hsa05012:Parkinson's disease]
ubiquitin-conjugating enzyme E2L 3,SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2L 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2L 3,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068094$chain:Ubiquitin-conjugating enzyme E2 L3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
zinc finger protein 143,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 143,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 143,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 143,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 143,UP_SEQ_FEATURE[850101457$chain:Zinc finger protein 143, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7]
zinc finger protein 705D; zinc finger protein 705C pseudogene,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 705D; zinc finger protein 705C pseudogene,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 705D; zinc finger protein 705C pseudogene,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 705D; zinc finger protein 705C pseudogene,UP_SEQ_FEATURE[850101875$chain:Zinc finger protein 705C, 850101876$chain:Zinc finger protein 705D, 850104552$domain:KRAB, 850117294$sequence conflict, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118724$zinc finger region:C2H2-type 4; degenerate]
zinc finger protein 833,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 833,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 833,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 833,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 833,UP_SEQ_FEATURE[850101949$chain:Zinc finger protein 833, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
